Preclinical Development of PEG-TNF
Small Business Information
PHOENIX PHARMACOLOGICS, INC.
PHOENIX PHARMACOLOGICS, INC., ASTECC FACILITY #A-217, LEXINGTON, KY, 40506
AbstractDESCRIPTION (provided by applicant): Unformulated human tumor necrosis factor( (huTNF() has anti-tumor activity in mice, but there is little difference between the effective and lethal doses. Systemic administration of unformulated huTNFalpha has been te
* information listed above is at the time of submission.